The prevention of contrast-induced nephropathy in Dutch hospitals

S. I. Moos, J. Stoker, L. F. M. Beenen, K. Flobbe, S. Bipat

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Abstract

Background: A major adverse effect of intravascularly administrated iodinated contrast medium is contrast-induced nephropathy (CIN). To reduce CIN incidence, two different prevention guidelines have been introduced in the Netherlands. Objective: Our goal was to assess the use of CIN prevention guidelines at the radiology departments in Dutch hospitals. Methods: We conducted a survey in all 90 Dutch hospitals with a radiology department. The questionnaire included questions about guideline execution (e.g. which guideline, (compliance) problems). Results: All responding (67/90) hospitals used a CIN prevention guideline. When asked who was responsible for conducting preventive measures in high-risk patients identified according to either guideline, the referring physician was responsible in 38 hospitals (56.7%); in 23 hospitals (34.3%) there was a specialised CIN outpatient clinic. Renal function was routinely checked after exposure to intravenous iodinated contrast medium in all CIN outpatient clinics (23) and radiology departments (2) when these were responsible for this measurement and in 52.6% (18/38) hospitals when the referring physicians were responsible. When asked if identifying patients at risk caused any problems, 47.8% reported problems. Conclusion: In all responding Dutch hospitals a CIN prevention guideline was used. There was considerable variation in the execution of the guidelines and there were substantial compliance problems. The follow-up procedure was more consistent in hospitals with an outpatient clinic
Original languageEnglish
Pages (from-to)97-103
JournalNetherlands journal of medicine
Volume71
Issue number2
Publication statusPublished - 2013

Cite this